EYENOVIA INC. - COMMON STOCK

Eyenovia Announces Participation at the 2023 International Consumer Electronics Show

20 12 2022 07:00:00 提供 Nasdaq GlobeNewswire

Eyenovia Announces FDA Acceptance of New Drug Application for MydCombi™ for In-Office Pupil Dilation

13 12 2022 07:00:02 提供 Nasdaq GlobeNewswire

Eyenovia Announces Promotion of Bren Kern to Chief Operating Officer and Corporate Vice President

08 12 2022 07:00:01 提供 Nasdaq GlobeNewswire

Eyenovia Announces $15 Million Credit Facility with Avenue Venture Debt Fund

29 11 2022 07:00:00 提供 Nasdaq GlobeNewswire

Eyenovia to Present at Upcoming BTIG Ophthalmology Day

23 11 2022 15:05:00 提供 Nasdaq GlobeNewswire

Eyenovia Reports Third Quarter 2022 Financial Results and Provides Business Update

10 11 2022 15:05:04 提供 Nasdaq GlobeNewswire

Eyenovia to Report Third Quarter 2022 Results on Thursday, November 10

03 11 2022 07:00:02 提供 Nasdaq GlobeNewswire

Eyenovia to Present at the American Academy of Optometry’s Annual Meeting

21 10 2022 07:00:00 提供 Nasdaq GlobeNewswire

Eyenovia Announces Positive Results from VISION-2 Phase 3 Study of MicroLine as a Potential On-Demand Treatment for Presbyopia

20 10 2022 07:00:02 提供 Nasdaq GlobeNewswire

Eyenovia Announces Planned Retirement of Lead Independent Director Ken Lee, Jr.

30 9 2022 07:00:00 提供 Nasdaq GlobeNewswire

Eyenovia to Present at Upcoming Healthcare Conferences

07 9 2022 07:00:03 提供 Nasdaq GlobeNewswire

Eyenovia to Participate in Multiple Medical Meetings in September

06 9 2022 07:00:03 提供 Nasdaq GlobeNewswire

Eyenovia Reports Second Quarter 2022 Financial Results

10 8 2022 15:05:01 提供 Nasdaq GlobeNewswire

Eyenovia to Report Second Quarter 2022 Results on Wednesday, August 10

04 8 2022 07:00:02 提供 Nasdaq GlobeNewswire

Eyenovia Announces Appointment of Ophthalmic Industry Veteran Michael Rowe as Chief Executive Officer and Board Member

27 7 2022 07:00:03 提供 Nasdaq GlobeNewswire

Eyenovia Provides Manufacturing Update and Announces Appointment of Bren Kern as SVP of Manufacturing and Operations

18 7 2022 07:00:01 提供 Nasdaq GlobeNewswire

Eyenovia Announces Appointments of Dr. Ellen Strahlman and Dr. Ram Palanki as New and Independent Members of its Board of Directors

07 7 2022 07:00:01 提供 Nasdaq GlobeNewswire

Eyenovia Strategic Partner Arctic Vision Enrolls First Patient in Phase III Clinical Trial of ARVN003 (MicroLine) for Presbyopia in China

06 7 2022 07:00:02 提供 Nasdaq GlobeNewswire

UPDATE: Eyenovia Announces Virtual 2022 Annual Meeting of Stockholders

09 6 2022 09:09:12 提供 Nasdaq GlobeNewswire

Eyenovia Announces Virtual 2022 Annual Meeting of Stockholders

09 6 2022 07:00:01 提供 Nasdaq GlobeNewswire